Hypoxia and fatty liver.

scientific article

Hypoxia and fatty liver. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.3748/WJG.V20.I41.15087
P932PMC publication ID4223242
P698PubMed publication ID25386057

P50authorNobuhito GodaQ52357474
P2093author name stringSatoko Shinjo
Tomohiro Suzuki
Mai Kanai
Takatomo Arai
P2860cites workROS: really involved in oxygen sensingQ80959540
HIF-1α induction suppresses excessive lipid accumulation in alcoholic fatty liver in miceQ84900157
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tensionQ24307473
Hypoxia-Inducible Factors and the Response to Hypoxic StressQ24629323
SIRT4 Regulates Fatty Acid Oxidation and Mitochondrial Gene Expression in Liver and Muscle CellsQ24633565
CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver diseaseQ26996634
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionQ27025886
Alcoholic liver disease: pathogenesis and new therapeutic targetsQ27690220
Mitogen-inducible gene 6 (MIG-6), adipophilin and tuftelin are inducible by hypoxiaQ28208424
Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB siteQ28286400
Regulation of hepatic lipogenesis by the transcription factor XBP1Q28507784
Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosisQ28582038
Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- miceQ28594703
Targeting hypoxia in cancer therapyQ29615491
Protein sensors for membrane sterolsQ29617313
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathwayQ29617805
PPARs and the complex journey to obesityQ29619271
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver diseaseQ29619334
Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxiaQ33312383
Carbohydrate-responsive element-binding protein (ChREBP) is a negative regulator of ARNT/HIF-1beta gene expression in pancreatic islet beta-cellsQ33556480
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repairQ33565774
A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitisQ44677145
Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factorQ45165652
Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxiaQ45166534
Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) TrialQ46575030
Elevated serum aminotransferase levels in children at risk for obstructive sleep apneaQ46813635
Liver enzymes and histology in obese patients with obstructive sleep apneaQ46843248
Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alphaQ46968793
Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysisQ48173331
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obeseQ48296229
Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxiaQ48420875
Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective studyQ48463175
Chronic intermittent hypoxia predisposes to liver injuryQ48473495
Chronic liver injury during obstructive sleep apneaQ48550777
Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in ratsQ48886060
ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liverQ50336015
Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the pickwick syndromeQ51239571
Hypoxia Converts Human Macrophages Into Triglyceride-Loaded Foam CellsQ59487770
High Hepatic SCD1 Activity Is Associated with Low Liver Fat Content in Healthy Subjects under a Lipogenic DietQ61862442
Control of fatty acid metabolism in ischemic and hypoxic heartsQ67342168
Effect of palmitate concentration on the relative contributions of the beta-oxidation pathway and citric acid cycle to total O2 consumption of isolated rat hepatocytesQ70565846
Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed ratsQ70618933
Effect of acute and chronic ethanol consumption on hepatic tissue oxygen tension in ratsQ71237493
On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P-450. Products of oxygen reductionQ71357736
Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivoQ73208990
Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL geneQ79074189
The role of hypoxia in the pathogenesis of alcoholic liver diseaseQ80133686
Ablation of ARNT/HIF1beta in liver alters gluconeogenesis, lipogenic gene expression, and serum ketonesQ33577124
Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistanceQ33604466
Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasisQ33685179
Oxygen: modulator of metabolic zonation and disease of the liverQ33828310
Macrophages: master regulators of inflammation and fibrosisQ34076279
Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.Q34091273
Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locusQ34139027
Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cellsQ34349638
Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidationQ34512108
Stra13/DEC1 and DEC2 inhibit sterol regulatory element binding protein-1c in a hypoxia-inducible factor-dependent mechanismQ34598057
Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypesQ34835012
Hypoxia-inducible factor-1α regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesisQ34996476
Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization.Q35010425
Xanthine oxidase mediates hypoxia-inducible factor-2α degradation by intermittent hypoxiaQ35016826
Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytesQ35034353
Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivoQ35065823
Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylationQ35072131
HIF hydroxylation and the mammalian oxygen-sensing pathwayQ35086143
Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosisQ35131965
Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implicationsQ35137857
High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxiaQ35216069
Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed miceQ35227126
Hypoxia is present in murine atherosclerotic plaques and has multiple adverse effects on macrophage lipid metabolismQ35529754
Human fatty liver disease: old questions and new insightsQ35588477
Intermittent hypoxia exacerbates metabolic effects of diet-induced obesityQ35702905
Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cellsQ35855600
Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic miceQ35913174
Lipid accumulation of hypoxic tissue culture cellsQ36077757
Stearoyl-CoA desaturase as a new drug target for obesity treatment.Q36100781
Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in miceQ36243894
Integration of oxygen signaling at the consensus HRE.Q36290265
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered miceQ36479005
Alcohol and lipid metabolismQ36588210
Hypoxia-inducible factor 1α regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes.Q36596160
The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cellsQ43495714
Obstructive sleep apnea is independently associated with insulin resistance.Q43903080
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferationQ36907933
Hypoxia-induced signaling in the cardiovascular systemQ36938391
Cytochrome P450 2E1 potentiates ethanol induction of hypoxia and HIF-1α in vivoQ37060555
Intermittent hypoxia degrades HIF-2alpha via calpains resulting in oxidative stress: implications for recurrent apnea-induced morbidities.Q37061642
Mitochondrial complex III regulates hypoxic activation of HIF.Q37064874
Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesityQ37077790
Molecular mechanisms of alcoholic fatty liverQ37078754
High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivoQ37087840
SREBPs: the crossroads of physiological and pathological lipid homeostasisQ37091373
Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY).Q37127287
Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient miceQ37138759
NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alphaQ37158836
Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR.Q37228613
Insulin resistance, inflammation, and non-alcoholic fatty liver diseaseQ37301920
Hypoxia-inducible factor 2 regulates hepatic lipid metabolismQ37302297
Oxygen sensors at the crossroad of metabolismQ37360663
Regulation of oxygen homeostasis by hypoxia-inducible factor 1.Q37443475
Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistanceQ37768004
Hypoxia: A Link between Fibrogenesis, Angiogenesis, and Carcinogenesis in Liver DiseaseQ37776185
Regulation of Nutrient Metabolism and InflammationQ37791883
Hypoxia and inflammationQ37842498
Hypoxia and hypoxia inducible factors: diverse roles in liver diseasesQ37961603
Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseasesQ38133457
Intermittent hypoxia induces hyperlipidemia in lean mice.Q38321740
Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese miceQ38323357
HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cellsQ39722018
Selective inhibition of hypoxia-inducible factor 1α ameliorates adipose tissue dysfunction.Q39760512
Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.Q40012178
Incomplete compensation of enhanced hepatic oxygen consumption in rats with alcoholic centrilobular liver necrosisQ41349177
Cytochrome P-4502E1: its physiological and pathological roleQ41441345
Is hypoxia involved in the mechanism of alcohol-induced liver injury?Q41595630
Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death.Q41765603
Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice.Q41988947
Metabolic alterations produced in the liver by chronic ethanol administration. Increased oxidative capacityQ42281596
A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivoQ42614205
A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistanceQ42812210
Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxiaQ42817965
Prevention and regression of non-alcoholic steatohepatitis (NASH) in a rat model by metabosartan, telmisartanQ42917230
Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseasesQ42935424
Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in miceQ43142149
Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activityQ43200840
Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN.Q43260810
P433issue41
P407language of work or nameEnglishQ1860
P304page(s)15087-15097
P577publication date2014-11-01
P1433published inWorld Journal of GastroenterologyQ15708885
P1476titleHypoxia and fatty liver
P478volume20

Reverse relations

cites work (P2860)
Q42089836Clinical characteristics of patients with diabetes mellitus and fatty liver diagnosed by liver/spleen Hounsfield units on CT scan
Q47145823Computational Modeling in Liver Surgery
Q51664532Genomics of human fatty liver disease reveal mechanistically linked lipid droplet-associated gene regulations in bland steatosis and nonalcoholic steatohepatitis.
Q36234613Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease
Q52665225Human physiological and metabolic responses to an attempted winter crossing of Antarctica: the effects of prolonged hypobaric hypoxia.
Q38898935Hypoxia in tissue repair and fibrosis
Q26752304Hypoxia-inducible factors as molecular targets for liver diseases
Q30251565Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease
Q54123025Improved oxygenation dramatically alters metabolism and gene expression in cultured primary mouse hepatocytes.
Q98779334Intake of Watermelon and Watermelon Byproducts in Male Mice Fed a Western-Style Obesogenic Diet Alters Hepatic Gene Expression Patterns, as Determined by RNA Sequencing
Q64115743Metabolomic and lipidomic plasma profile changes in human participants ascending to Everest Base Camp
Q92855752Obstructive Sleep Apnea and the Liver
Q38972126Possible association between Helicobacter pylori infection and nonalcoholic fatty liver disease
Q58800699Post-mortem analysis of lactate concentration in diabetics and metformin poisonings
Q92967057Pseudolesion in the right parafissural liver parenchyma on CT: The base is found in embryology and collagen content
Q41258278The Apelin Receptor APJ in Hematopoietic Stem Cells/Progenitor Cells in the Early Stage of Non-Alcoholic Steatohepatitis.
Q89110155Underrated enemy - from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract

Search more.